Workflow Orchestration for Phase I Clinical

Data Characteristics

Phase I clinical trial pharmacovigilance data comes from short-term, high-frequency observations of a few healthy subjects or specific patient groups. Data types are primarily structured and semi-structured. This includes vital signs from Case Report Forms (CRF), lab results, Adverse Event (AE) or Serious Adverse Event (SAE) records, and medication history. Electronic Data Capture (EDC) systems typically record this data. Update frequency is high; AE reports can generate within hours. Document structures follow ICH GCP E2B standards. AE descriptions often contain free text, including medical terminology, anatomical locations, symptoms, and severity. Key fields include AE_TERM, ONSET_DATE, OUTCOME, and DRUG_RELATEDNESS. Units cover standard measurements (e.g., mg, mmol/L) and time units (e.g., days, hours).

Constraints on Workflow Orchestration

Phase I clinical data's high update frequency and sensitivity require workflows with fast response times and high throughput. This ensures timely AE capture and processing. The coexistence of structured data and free text means workflows need NLP techniques for data parsing. This extracts critical information from unstructured descriptions, such as identifying synonyms or medical abbreviations in AE_TERM. ICH GCP E2B standards constrain data output formats, so workflows must integrate format conversion modules at the end. With a limited number of subjects, each AE can be highly valuable. Therefore, workflow error handling mechanisms must be robust, capturing any data anomalies and triggering manual intervention. Evaluating key fields like DRUG_RELATEDNESS may require external knowledge bases or expert systems for auxiliary judgment.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`maxContext`	`2000 characters`	Phase I AE descriptions are usually brief; this avoids redundant information that could interfere with judgment.
`Recall Count`	`Top 5`	This ensures precise matching of relevant historical records or knowledge from a limited number of adverse events.
`Similarity Threshold`	`0.85`	A high threshold identifies highly similar adverse events, aiding in assessing drug relatedness.
`PARSE_FILE_TIMEOUT_SECONDS`	`60 seconds`	Phase I reports are small; individual file parsing should complete quickly.
`Rerank Return Count`	`Top 3`	Further refines recall results, focusing on the most relevant AE information.
`Segment Length`	`400 characters`	Adapts to the granularity of AE descriptions, ensuring critical information is not truncated.

Common Mistakes

Calling a tool results in Invalid API Key or Authentication Failed. This happens when external API authentication information is not correctly configured in the workflow's environment variables.
The AE_TERM field extraction is empty or inaccurate. This occurs when the workflow's natural language processing module fails to effectively recognize medical terminology variants or abbreviations, often due to not loading the corresponding medical dictionary.
Workflow execution times out, especially during data format conversion or complex logical judgments. This is typically due to a single module's processing taking too long, without setting reasonable timeout parameters or insufficient parallel processing optimization.

Validation Checklist

Submit a test report with a typical AE description. Observe if the workflow completes event extraction and outputs structured data compliant with ICH GCP E2B standards within 5 seconds.
Manually simulate an AE report containing ambiguous medical terms or abbreviations. Check the workflow's accuracy in identifying the AE_TERM field, ensuring it correctly matches standard terminology.
Continuously submit 100 simulated AE reports. Monitor the workflow's total execution time and resource consumption. Confirm stable response under high concurrency.
Examine the DRUG_RELATEDNESS field in the workflow's output. Compare it with human judgment to confirm the effectiveness of the auxiliary judgment module.

The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.